MENDITTO, ENRICA
 Distribuzione geografica
Continente #
AS - Asia 5.528
EU - Europa 4.988
NA - Nord America 4.756
SA - Sud America 832
AF - Africa 181
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 4
Totale 16.300
Nazione #
US - Stati Uniti d'America 4.522
SG - Singapore 3.179
RU - Federazione Russa 2.503
CN - Cina 1.127
IT - Italia 853
BR - Brasile 679
HK - Hong Kong 498
VN - Vietnam 377
NL - Olanda 348
DE - Germania 340
FI - Finlandia 269
GB - Regno Unito 142
CA - Canada 137
IE - Irlanda 101
SE - Svezia 98
FR - Francia 69
IN - India 68
CI - Costa d'Avorio 64
UA - Ucraina 62
MX - Messico 60
AR - Argentina 59
BD - Bangladesh 50
PL - Polonia 42
ZA - Sudafrica 42
AT - Austria 37
ES - Italia 33
KR - Corea 31
EC - Ecuador 28
TR - Turchia 26
ID - Indonesia 24
IQ - Iraq 20
JP - Giappone 20
CO - Colombia 16
LT - Lituania 16
IR - Iran 15
PY - Paraguay 15
MA - Marocco 14
BE - Belgio 13
KE - Kenya 13
PE - Perù 13
PK - Pakistan 13
AE - Emirati Arabi Uniti 9
UY - Uruguay 9
UZ - Uzbekistan 9
AU - Australia 8
AZ - Azerbaigian 8
DK - Danimarca 8
DZ - Algeria 8
GR - Grecia 8
CH - Svizzera 7
DO - Repubblica Dominicana 7
TN - Tunisia 7
VE - Venezuela 7
EG - Egitto 6
IL - Israele 6
JM - Giamaica 6
JO - Giordania 6
SN - Senegal 6
BG - Bulgaria 5
NP - Nepal 5
PH - Filippine 5
RO - Romania 5
SA - Arabia Saudita 5
CZ - Repubblica Ceca 4
HN - Honduras 4
MY - Malesia 4
CL - Cile 3
EE - Estonia 3
GT - Guatemala 3
LB - Libano 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
AL - Albania 2
BF - Burkina Faso 2
BS - Bahamas 2
CY - Cipro 2
DM - Dominica 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
GF - Guiana Francese 2
HT - Haiti 2
HU - Ungheria 2
KG - Kirghizistan 2
LC - Santa Lucia 2
LY - Libia 2
MD - Moldavia 2
NI - Nicaragua 2
NO - Norvegia 2
PS - Palestinian Territory 2
RS - Serbia 2
SI - Slovenia 2
SV - El Salvador 2
UG - Uganda 2
XK - ???statistics.table.value.countryCode.XK??? 2
YE - Yemen 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
Totale 16.270
Città #
Singapore 1.395
Moscow 584
Hong Kong 497
Chandler 451
Ashburn 446
Santa Clara 437
Beijing 382
Amsterdam 301
Naples 221
Millbury 195
Hefei 163
Los Angeles 162
Munich 146
Boston 128
Ho Chi Minh City 120
Princeton 110
Nanjing 104
Des Moines 99
Napoli 93
Lappeenranta 83
Buffalo 76
New York 75
Lawrence 74
Redondo Beach 71
Hanoi 70
Ottawa 68
São Paulo 66
Wilmington 57
The Dalles 56
Turku 56
Dallas 46
Jacksonville 45
Dong Ket 44
Nuremberg 42
Woodbridge 42
Frankfurt am Main 40
Helsinki 39
Milan 37
Warsaw 34
Nanchang 32
Atlanta 31
Chicago 31
Mexico City 31
Montreal 30
Rio de Janeiro 30
Orem 29
Poplar 28
Seoul 28
Stockholm 28
Rome 27
Tianjin 27
Brooklyn 26
Hebei 26
Shenyang 25
London 24
Phoenix 24
Falkenstein 23
Chennai 21
Houston 21
Denver 20
Redwood City 19
Seattle 19
Tokyo 19
Washington 19
Boardman 15
Fairfield 15
Salerno 15
Sciacca 15
Toronto 15
Haiphong 14
Jiaxing 14
Johannesburg 14
Belo Horizonte 13
Da Nang 13
Düsseldorf 13
Querétaro 13
Vienna 13
Brasília 12
Porto Alegre 12
Nairobi 11
Quito 11
Biên Hòa 10
Ninh Bình 10
Ankara 9
Campinas 9
Council Bluffs 9
Curitiba 9
Hải Dương 9
Manchester 9
Montevideo 9
Mumbai 9
Salvador 9
San Francisco 9
Secaucus 9
Vancouver 9
Baku 8
Bengaluru 8
Bologna 8
Changsha 8
Lauterbourg 8
Totale 8.189
Nome #
Evidence-based directions for polypharmacy revision: The experience gained by the campania reference site in the framework of the eip-aha action group A1 and of the friendd pilot study 194
[Evaluation of therapeutical appropriateness in psychiatric treatment of schizophrenia, by integrating computer data records with clinical audit results] 189
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry 156
Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air® App 141
PERSISTENZA IN TERAPIA NEI SOGGETTI IN TRATTAMENTO CON FARMACI PER L' OSTEOPOROSI 137
Valutazione economica dello studio AVERT 133
Rates and reasons for lack of persistence with anti-osteoporotic drugs: analysis of the Campania Region Database 129
The Tosca Registry: An Ongoing, Observational, Multicenter Registry for Chronic Heart Failure 129
Drug Utilization and Measurement of Medication Adherence: A Real World Study of Psoriasis in Italy 127
ANALISI DEI PROFILI PRESCRITTIVI DEGLI ANTIPSICOTICI ATIPICI NELLA ASL CASERTA 125
Cost Analysis of an Intensive Care Unit 122
Osteoporosis drugs in real-world clinical practice: an analysis of persistence 117
La terapia farmacologica anti-osteoporotica: analisi della persistenza in Regione Campania. 117
Differences in drug use between men and women: An Italian cross sectional study 116
Determinants of Non-Persistence to Antiosteoporotic Drugs by Using Administrative Database 115
How healthy is community-dwelling elderly population? Results from Southern Italy 114
Impact of Cost- Containment Policies on Biosimilars Market 113
IMPATTO DELLE POLITICHE DI COST-CONTAINMENT SUL MERCATO DEI BIOSIMILARI 111
Next-generation ARIA care pathways for rhinitis and asthma: A model for multimorbid chronic diseases 111
Cost Analysis of an intensive care unit 110
Antibiotic prescription in Southern Italian outpatients: Real-world data analysis of prevalence, socioeconomic and sociodemographic variables and geographic variability 110
Consumption of biosimilar drugs in Campania Region in the years 2009 -2012 109
Cost-Effectiveness of Treatment Optimisation with Biomarkers for Immunotherapy in Solid Tumours: A Systematic Review 108
Gastroesophageal reflux disease (GERD) cost of care: Role of naive and relapsed symptoms in general practice 108
Le politiche di compartecipazione alla spesa farmaceutica 106
A Large-Scale Longitudinal Population-Based Study of Risk Reduction of Cardiovascular Complications in Patients on Bolus Insulin Analogues 106
Are you more concerned about or relieved by medicines? An explorative randomized study of the impact of telephone counseling by pharmacists on patients' beliefs regarding medicines and blood pressure control. 106
Innovative Approaches to Active and Healthy Ageing: Campania Experience to Improve the Adoption of Innovative Good Practices 105
Predictors of non-persistence on statin treatments in Italy: a retrospective cohort study in primary care. 104
Proton pump inhibitors prescribing following the introduction of generic drugs 104
Baseline drug treatments as indicators of increased risk of COVID-19 mortality in Spain and Italy 104
Valutazione economica dello studio IDEAL 103
Lower incidence of macrovascular complications in patients on insulin glargine versus those on basal human insulins: A population-basad cohort study in Italy. 103
LA VALUTAZIONE DELLA COMUNICAZIONE MEDICO-PAZIENTE: LA ESPERIENZA DELLA A.O.R.N. A CARDARELLI 103
Influence of generic drugs on proton pump inhibitor prescription in primary care. 102
PPI general practitioners’prescribing in the treatment of acid-related disorders: the impact of generic PPI launch into the pharmaceutical market in Italy 102
Prevalence of chronic obstructive pulmonary disease from administrative health services databases. 102
Postvaccination SARS-CoV-2 Infections among Healthcare Professionals: A Real World Evidence Study 101
Prevalence of antibiotic prescription in southern Italian outpatients: real-world data analysis of socioeconomic and sociodemographic variables at a municipality level 101
Aligning the good practice mask with the objectives of the European innovation partnership on active and healthy ageing 101
Assessment of surgeon communication skills from the patient perspective: A national evaluation using the Communication Assessment Tool 101
Influenza dei farmaci generici sulle dinamiche prescrittive degli inibitori di pompa protonica in medicina generale 100
Three-Year Health Care Expenditures in Diabetic Patients Receiving Rapid-Acting Insulin Analogues Versus Those on Human Regular Insulin 100
Prescription Appropriateness of Drugs for Peptic Ulcer and Gastro-Esophageal Reflux Disease: Baseline Assessment in the LAPTOP-PPI Cluster Randomized Trial 99
Imaging tests in staging and surveillance of early breast cancer in Italy. changes in routine clinical practice and costs implications 99
Drug Utilization Pattern of Antibiotics: The Role of Age, Sex and Municipalities in Determining Variation 99
Lower rate of cardiovascular complications in patients on bolus insulin analogues: a retrospective population-based cohort study. 98
In real clinical practice osteoporosis drugs are taken for a very short period: analysis of persistence in the Campania region 98
AC4 - RETROSPECTIVE ANALYSIS OF INAPPROPRIATE MEDICATION PRESCRIPTION INDICATORS IN ELDERLY POPULATION IN ITALY 98
THE EFFECT OF A TELEPHONE COUNSELING INTERVENTION BY PHARMACIST ON PATIENTS' BELIEFS ABOUT MEDICINES AND BLOOD PRESSURE CONTROL 98
ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice 97
Doctors commitment and long-term effectiveness for cost containment policies: lesson learned from biosimilar drugs 97
THE USE OF REAL WORLD DATA TO BUILD ECONOMIC MODELS: A CASE STUDY OF OSTEOPOROSIS 97
Longitudinal Trajectory Modeling to Assess Adherence to Sacubitril/Valsartan among Patients with Heart Failure 96
La gestione della malattia acido correlata nella medicina di primo livello. Sinergie di utilizzo degli archivi informatizzati per l’informatizzati per l’informazione e la formazione e la formazione professione. 96
Analysis of Prescribing Patterns of Atypical Antipsychotics in Lhu Caserta 96
DIFFERENZE DI GENERE NELL???USO DEI FARMACI. ANALISI DEI DATI DI PRESCRIZIONE FARMACEUTICA IN ITALIA 96
Cost analysis of anti-osteoporotic drugs in real-world clinical practice 96
GENDER DIFFERENCES IN MEDICATION TAKING BEHAVIOUR: A CASE OF OSTEOPOROSIS 96
Comorbidity in an Older Population with Type-2 Diabetes Mellitus: Identification of the Characteristics and Healthcare Utilization of High-Cost Patients 96
Drug-utilisation profiles and COVID-19 96
A pragmatic controlled trial to improve the appropriate prescription of drugs in adult outpatients: Design and rationale of the EDU.RE.DRUG study 96
Aspetti epidemiologici ed economici del diabete in Campania: analisi dei dati di prescrizione attraverso farmaci traccianti 95
Proton pump inhibitors market in primary care setting. 95
Valutazione dell'impatto sulla spesa farmaceutica dell'organizzazione logistica 94
Treatment Patterns And Drug-Related Costs For Patients with Psoriasis on Biologic Therapy: A Retrospective Cohort Study In Southern Italy 94
Treatment patterns and medication adherence among newly diagnosed patients with migraine: a drug utilisation study 94
Development and validation of a clinical risk score to predict the risk of SARS-CoV-2 infection from administrative data: A population-based cohort study from Italy 94
Evaluation of Factors Associated With Appropriate Drug Prescription and Effectiveness of Informative and Educational Interventions-The EDU.RE.DRUG Project 93
Prevalence and Characterization of Potential PPI-Clopidogrel Interaction in a Prescription Database in 2006-2009 93
Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA 93
Gender-Related Behaviors in Drug Consumption In Italy 91
Predictors of new oral anticoagulant drug initiation as opposed to warfarin in elderly adults: A retrospective observational study in Southern Italy 91
PSY90 - RETROSPECTIVE ANALYSIS OF ADMINISTRATIVE DATA TO ASSESS ADHERENCE, PHARMACOUTILIZATION AND COSTS OF BIOLOGICAL THERAPY TREATMENT OF PSORIASIS IN SOUTHERN ITALIAN SETTING 91
Next-generation care pathways for allergic rhinitis and asthma multimorbidity: A model for multimorbid non-communicable diseases—Meeting Report (Part 1) 91
Cost-effectiveness of treatment optimisation with biomarkers for immunotherapy in solid tumours: A systematic review protocol 91
Valutazione economica dello studio CARDS 90
Pharmacoeconomic consequences of losartan therapy in patients undergoing Diabetes End-Stage Renal Disease. 90
Persistence at one year with antiosteoporotic drugs in Southern Italy: analysis of administrative databases. 90
Persistence with antiosteoporotic drugs: a retrospective population-based color study. 90
THU0503 Cost analysis of anti-osteoporotic drugs in real-world clinical practice 90
THU0504 Utilisation of anti-osteoporotic drugs in real-world data: a study of gender-related differences 90
The value of the polypill in cardiovascular disease: an Italian multidisciplinary Delphi panel consensus 90
Biological therapy utilization, switching, and cost among patients with psoriasis: Retrospective analysis of administrative databases in southern Italy 89
Assessment of Patterns of Initiation of Oral Anticoagulant Therapy in Hypertensive Patients with Atrial Fibrillation 89
Next-generation care pathways for allergic rhinitis and asthma multimorbidity: A model for multimorbid non-communicable diseases—Meeting Report (Part 2) 89
Persistence as a robust indicator of medication adherence-related quality and performance 89
Adaptation of communication assessment tool for community pharmacists in medication adherence and minor diseases management 88
The European Innovation Partnership on Active and Healthy Ageing Synergies: Protocol for a Prospective Observational Study to Measure the Impact of a Community-Based Program on Prevention and Mitigation of Frailty (ICP - PMF) in Community-Dwelling Older Adults 88
Changes in multimorbidity and polypharmacy patterns in young and adult population over a 4-year period: A 2011–2015 comparison using real-world data 88
Cost effectiveness analysis of bisoprolol treatment for heart failure 87
Inappropriate medication prescribing among elderly patients in Italy 87
Initial Therapy, Regimen Change, and Persistence in a Spanish Cohort of Newly Treated Type 2 Diabetes Patients: A Retrospective, Observational Study Using Real-World Data 87
Assessment and potential determinants of compliance and persistence to antiosteoporosis therapy in Italy 86
THU0474 Utilisation of anti-osteoporotic drugs in real-world data: an analysis of persistence to therapy and risk of fracture 86
Developing and piloting a communication assessment tool assessing patient perspectives on communication with pharmacists (CAT-Pharm) 86
Consumption of biosimilar drugs in Campania Region for the years 2008-2011 85
Self-Assessment of Adherence to Medication: A Case Study in Campania Region Community-Dwelling Population 85
MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence 85
2019 ARIA Care pathways for allergen immunotherapy 85
Totale 10.248
Categoria #
all - tutte 55.273
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.273


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021305 0 0 0 0 0 130 20 14 35 19 20 67
2021/20221.013 8 3 11 1 9 44 4 28 135 84 239 447
2022/20231.301 195 79 41 61 127 135 3 98 173 283 77 29
2023/20241.089 36 154 183 82 64 100 19 112 17 68 191 63
2024/20255.592 267 270 19 58 236 384 571 364 370 571 2.003 479
2025/20266.154 1.155 667 994 1.081 1.832 425 0 0 0 0 0 0
Totale 16.715